Depression in Alzheimer's disease might be associated with apolipoprotein E ε4 allele frequency in women but not in men

Dementia and Geriatric Cognitive Disorders

Volumn 14, Issue 2, 2002, Pages 59-63

  Müller Thomsen, Tomas ^a   Arlt, Sönke ^b   Ganzer, Stefanie ^b   Mann, Ulrike ^b   Mass, Reinhard ^b   Naber, Dieter ^b   Beisiegel, Ulrike ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b NONE

Author keywords

Alzheimer's disease; Apolipoprotein E; Depression; Gender difference; Gene frequency

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIOECONOMICS;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DEPRESSION; FEMALE; GENE DOSAGE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS;

EID: 0036978132     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064926     Document Type: Article

References (36)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
2. Zubenko GS, Henderson R, Stiffler JS, Stabler S, Rosen J, Kaplan BB: Association of the APOE epsilon 4 allele with clinical subtypes of late life depression. Biol Psychiatry 1996;40: 1008-1016.
3. Förstl H, Czech C, Sattel H, Geiger-Kabisch C, Besthorn C, Kreger S, Mönning U, Hartmann T, Masters C, Beyreuther K: Apolipoprotein E and Alzheimer-Demenz. Nervenarzt 1994;65: 780-786.
4. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-1356.
5. Schmand B, Hooijer C, Jonker C, Lindeboom J, Havekes LM: Apolipoprotein E phenotype is not related to late-life depression in a population-based sample. Soc Psychiatry Psychiatr Epidemiol 1998;33:21-26.
6. Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM: Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol 2000;57:1579-1583.
7. Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Müller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, Staehelin H, Growdon JH, Tanzi RE, Hyman BT: Genetic association of an alpha2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease. Hum Mol Genet 1998;7:1953-1956.
8. Zill P, Bürger K, Behrens S, Hampel H, Padberg F, Boetsch T, Möller HJ, Ackenheil M, Bondy B: Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients. Neurosci Lett 2000;294:69-72.
9. Wragg RE, Jeste DV: Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989;146:577-587.
10. Jorm AF: Is depression a risk factor for dementia or cognitive decline? A review. Gerontology 2000;46:219-227.
11. Martorell L, Virgos C, Valero J, Coll G, Figuera L, Joven J, Pocovi M, Labad A, Vilella E: Schizophrenic women with the APOE epsilon4 allele have a worse prognosis than those without it. Mol Psychiatry 20001;6:307-310.
12. Thibaut F, Coron B, Hannequin D, Segard L, Martin C, Dollfus S, Campion D, Frebourg T, Petit M: No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients. Schizophr Res 1998; 30:149-153.
13. Oliveri RL, Nicoletti G, Cittadella R, Manna I, Branca D, Zappia M, Gambardella A, Caracciolo M, Quattrone A: Apolipoprotein E polymorphisms and Parkinson's disease. Neurosci Lett 1999;277:83-86.
14. Krishnan KR, Tupler LA, Ritchie JC, McDonald WM, Knight DL, Nemeroff CB, Carroll BJ: Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry 1996;40:69-71.
15. Cantillon M, Harwood D, Barker W, St George-Hyslop P, Tsuda T, Ekatarina R, Duara R: No association between apolipoprotein E genotype and late-onset depression in Alzheimer's disease. Biol Psychiatry 1997;4:246-248.
16. Mauricio M, O'Hara R, Yesavage JA, Friedman L, Kraemer HC, Van de Water M, Murphy GM: A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults. Am J Geriatr Psychiatry 2000;8:196-200.
17. Class CA, Unverzagt FW, Gao S, Sahota A, Hall KS, Hendrie HC: The association between ApoE genotype and depressive symptoms in elderly African-American subject. Am J Geriatr Psychiatry 1997;5:339-343.
18. Papassotiropoulos A, Bagli M, Jessen F, Rao ML, Schwab SG, Heun R: Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E. Dement Geriatr Cogn Disord 1999;10:258-261.
19. Ramachandran G, Marder K, Tang M, Schofield PW, Chun M, Devanand DP, Stern Y, Mayeux R: A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996;47: 256-259.
20. Cacabelos R, Rodriguez B, Carrera C, Caamano J, Beyer K, Lao JI, Sellers MA: APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol 1996;18:693-706.
21. Weiner MF, Vega G, Risser RC, Honig LS, Cullum CM, Crumpacker D, Rosenberg RN: Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 1999;45:633-638.
22. Harwood DG, Barker WW, Ownby RL, St George-Hyslop P, Duara Z: Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry 1999;7:119-123.
23. Forsell Y, Corder EH, Basun H, Lannfelt L, Viitanen M, Winblad B: Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol Psychiatry 1997;42:898-903.
24. Lopez OL, Kamboh MI, Becker JT, Kaufer DI, DeKosky ST: The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997;49:794-797.
25. Levy ML, Cummings JL, Fairbanks LA, Sultzer DL, Small GW: Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol Psychiatry 1999;45:422-425.
26. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC: A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry 1997;41:851-856.
27. Lyketsos CG, Tune LE, Pearlson G, Steele C: Major depression in Alzheimer's disease. An interaction between gender and family history. Psychosomatics 1996;37:380-384.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
29. Dilling H, Mombout W, Schmidt MH, Schulte-Marquort E: Internationale Klassifikation psychischer Störungen ICD-10, ed 2, revised. Bern, Huber, 2000, Kapitel V (F).
30. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
31. Montgomery SA, Åsberg: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:282-289.
32. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage by HhaI. J Lipid Res 1990; 31:545-548.
33. Geerlings MI, Schmand B, Braam AW, Jonker C, Bouter LM, van Tilburg W: Depressive symptoms and risk of Alzheimer's disease in more highly educated older people. J Am Geriatr Soc 2000;48:1092-1097.
34. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL: The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1988;24:233-242.
35. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL: Neuropathology of aminergic nuclei in Alzheimer's disease. Prog Clin Biol Res 1989; 317:353-365.
36. Förstl H, Burns A, Luthert P, Cairns N, Lantos P, Levy R: Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med 1992;22:877-884.